{"cluster": 48, "subcluster": 70, "abstract_summ": "Receiver operating characteristic analysis distinguished severe and nonsevere patients according to KL\u20106 serum levels and the best cut\u2010off value was 406.5 U/mL. NK cell analysis and assay of KL\u20106 in serum can help identify severe COVID\u201019 patients.The purpose of this study is to explore changes in markers of severe disease in COVID\u201019 patients.This preliminary study analyzed serum concentrations of KL\u20106 in patients with coronavirus disease (COVID\u201019) to verify its potential as a prognostic biomarker of severity.Nineteen studies reported NLR values, while five studies reported PLR values between severe and non-severe COVID-19 patients.Higher levels of NLR (SMD: 2.80, 95% CI: 2.12 - 3.48, P < 0.00001) and PLR (SMD: 1.82, 95% CI: 1.03 - 2.61, P < 0.00001)) were seen in patients with severe disease compared to non-severe disease.", "title_summ": "Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19The Neutrophil Lymphocyte Ratio (NLR), Platelet Lymphocyte Ratio (PLR) and routine hematological parameters of COVID-19 Patient : A perspective of the Indian scenario from a frontline pilot study of 32 COVID-19 cases in a Tertiary Care Institute of North IndiaSerum Mycoplasma Pneumoniae IgG in COVID-19: A Protective FactorThe role of interleukin\u20106 in monitoring severe case of coronavirus disease 2019Serum KL\u20106 concentrations as a novel biomarker of severe COVID\u201019Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID\u201019Using IL\u20102R/lymphocytes for predicting the clinical progression of patients with COVID\u201019Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID\u201019) infected patientsThe diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patientsNeutrophil\u2010to\u2010lymphocyte ratio and lymphocyte\u2010to\u2010C\u2010reactive protein ratio in patients with severe coronavirus disease 2019 (COVID\u201019): A meta\u2010analysis", "title_abstract_phrases": "Receiver operating characteristic analysis distinguished severe and nonsevere patients according to KL\u20106 serum levels and the best cut\u2010off value was 406.5 U/mL. NK cell analysis and assay of KL\u20106 in serum can help identify severe COVID\u201019 patients.The purpose of this study is to explore changes in markers of severe disease in COVID\u201019 patients.This preliminary study analyzed serum concentrations of KL\u20106 in patients with coronavirus disease (COVID\u201019) to verify its potential as a prognostic biomarker of severity.Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID\u201019) infected patientsWe explored the relationships between lymphocyte subsets, cytokines, pulmonary inflammation index (PII) and disease evolution in patients with (corona virus disease 2019) COVID\u201019.Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID\u201019To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe coronavirus disease 2019 (COVID\u201019)."}